Transcranial Magnetic Stimulator

DEVICE5 trials

Sponsors

US Department of Veterans Affairs, University of Calgary, Neuronetics

Conditions

Antepartum DepressionDepressionMajor Depressive DisorderPeripartum DepressionPostpartum Depression

Phase 1

Accelerated Transcranial Magnetic Stimulation (TMS) for Depression

CompletedNCT00248768

US Department of Veterans AffairsDepression

Start: 2005-02-28End: 2009-06-30Updated: 2014-09-19

D-Cycloserine+iTBS PK Study

CompletedNCT05731323

University of CalgaryMajor Depressive Disorder

Start: 2022-10-12End: 2023-06-22Updated: 2023-09-11

Phase 2

Adjunctive D-Cycloserine in Major Depressive Disorder

CompletedNCT03937596

University of CalgaryMajor Depressive Disorder

Start: 2019-12-01End: 2020-12-24Updated: 2022-01-10

Unknown Phase

rTMS for Peripartum Depression

WithdrawnNCT03949465

University of CalgaryAntepartum Depression, Peripartum Depression, Postpartum Depression

Start: 2023-05-18End: 2023-05-18Updated: 2023-09-13

Treatment of Major Depressive Disorder in the UK Using TMS Therapy

WithdrawnNCT04217837

NeuroneticsMajor Depressive Disorder

Start: 2020-03-31End: 2022-02-28Updated: 2021-10-08

Related Papers

Self-criticism predicts antidepressant effects of intermittent theta-burst stimulation in Major Depressive Disorder.

2024-12-031 citations

Efficacy of Adjunctive <scp>D</scp>-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder

JAMA Psychiatry2022-10-1276 citations